Aimei Health Technology Co Ltd
AFJK32.010USD
-4.020-11.16%
收盘 12/22, 16:00（美东）报价延迟15分钟
195.96M总市值
162.45市盈率 TTM
关于 Aimei Health Technology Co Ltd 公司
Aimei Health Technology Co., Ltd. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. It has not generated any revenues.
Aimei Health Technology Co Ltd简介
公司代码AFJK
公司名称Aimei Health Technology Co Ltd
上市日期Jan 22, 2024
CEOXie (Junheng)
员工数量- -
证券类型Ordinary Share
年结日Jan 22
公司地址10 East 53rd Street
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10022
电话134678035200
网址
公司代码AFJK
上市日期Jan 22, 2024
CEOXie (Junheng)
Aimei Health Technology Co Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Lin Bao
Ms. Lin Bao
Independent Director
Independent Director
20.00K
--
Dr. Julianne Huh
Dr. Julianne Huh
Independent Director
Independent Director
20.00K
--
Mr. Junheng Xie
Mr. Junheng Xie
Chief Executive Officer, Company Secretary, Director
Chief Executive Officer, Company Secretary, Director
--
--
Mr. Heung Ming (Henry) Wong
Mr. Heung Ming (Henry) Wong
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Robin Hoksnes Karlsen
Mr. Robin Hoksnes Karlsen
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Lin Bao
Ms. Lin Bao
Independent Director
Independent Director
20.00K
--
Dr. Julianne Huh
Dr. Julianne Huh
Independent Director
Independent Director
20.00K
--
Mr. Junheng Xie
Mr. Junheng Xie
Chief Executive Officer, Company Secretary, Director
Chief Executive Officer, Company Secretary, Director
--
--
Mr. Heung Ming (Henry) Wong
Mr. Heung Ming (Henry) Wong
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Robin Hoksnes Karlsen
Mr. Robin Hoksnes Karlsen
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Aimei Investment Ltd
31.12%
Karpus Investment Management
16.76%
First Trust Capital Management L.P.
11.11%
Mizuho Securities USA, LLC.
9.00%
Berkley Dean & Company, Inc.
7.36%
其他
24.66%
持股股东
持股股东
占比
Aimei Investment Ltd
31.12%
Karpus Investment Management
16.76%
First Trust Capital Management L.P.
11.11%
Mizuho Securities USA, LLC.
9.00%
Berkley Dean & Company, Inc.
7.36%
其他
24.66%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
31.56%
Corporation
31.12%
Investment Advisor
12.21%
Research Firm
11.32%
Hedge Fund
5.10%
Individual Investor
2.48%
其他
6.20%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
47
3.69M
130.35%
-401.75K
2025Q3
47
4.09M
130.40%
-13.09K
2025Q2
46
4.10M
130.94%
-167.41K
2025Q1
45
4.14M
139.59%
-4.40M
2024Q4
41
6.49M
80.35%
-390.45K
2024Q3
38
6.88M
76.17%
+277.59K
2024Q2
36
6.60M
72.17%
+59.52K
2024Q1
30
6.54M
18.76%
+4.85M
2023Q4
1
476.43K
0.00%
+476.43K
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Aimei Investment Ltd
1.91M
31.12%
--
--
Mar 28, 2025
Karpus Investment Management
1.06M
17.34%
-17.69K
-1.64%
Jun 30, 2025
First Trust Capital Management L.P.
680.00K
11.11%
--
--
Jun 30, 2025
Mizuho Securities USA, LLC.
550.60K
8.99%
+600.00
+0.11%
Jun 30, 2025
Berkley Dean & Company, Inc.
425.36K
6.95%
+81.23K
+23.61%
Jun 30, 2025
CrossingBridge Advisors, LLC
193.29K
3.16%
+66.90K
+52.94%
Jun 30, 2025
The Quarry LP
157.08K
2.57%
--
--
Jun 30, 2025
Glazer Capital, LLC
187.16K
3.06%
-112.84K
-37.61%
Jun 30, 2025
Sage Rock Capital Management LP
140.00K
2.29%
--
--
Sep 30, 2024
TD Securities, Inc.
132.06K
2.16%
-13.37K
-9.19%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
CrossingBridge Pre-Merger SPAC ETF
5.94%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
占比5.94%
RiverNorth Enhanced Pre-Merger SPAC ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Aimei Health Technology Co Ltd的前五大股东是谁？
Aimei Health Technology Co Ltd 的前五大股东如下：
Aimei Investment Ltd持有股份：1.91M，占总股份比例：31.12%。
Karpus Investment Management持有股份：1.06M，占总股份比例：17.34%。
First Trust Capital Management L.P.持有股份：680.00K，占总股份比例：11.11%。
Mizuho Securities USA, LLC.持有股份：550.60K，占总股份比例：8.99%。
Berkley Dean & Company, Inc.持有股份：425.36K，占总股份比例：6.95%。
Aimei Investment Ltd持有股份：1.91M，占总股份比例：31.12%。
Karpus Investment Management持有股份：1.06M，占总股份比例：17.34%。
First Trust Capital Management L.P.持有股份：680.00K，占总股份比例：11.11%。
Mizuho Securities USA, LLC.持有股份：550.60K，占总股份比例：8.99%。
Berkley Dean & Company, Inc.持有股份：425.36K，占总股份比例：6.95%。
Aimei Health Technology Co Ltd的前三大股东类型是什么？
Aimei Health Technology Co Ltd 的前三大股东类型分别是：
Aimei Investment Ltd
Karpus Investment Management
First Trust Capital Management L.P.
Aimei Investment Ltd
Karpus Investment Management
First Trust Capital Management L.P.
有多少机构持有Aimei Health Technology Co Ltd(AFJK)的股份？
截至2025Q4，共有47家机构持有Aimei Health Technology Co Ltd的股份，合计持有的股份价值约为3.69M，占公司总股份的130.35%。与2025Q3相比，机构持股有所增加，增幅为-0.05%。
哪个业务部门对Aimei Health Technology Co Ltd的收入贡献最大？
在--，--业务部门对Aimei Health Technology Co Ltd的收入贡献最大，创收--，占总收入的--%。
